Crohn's-disease, treatmentNatalizumab, therapeutic use
Most current drug delivery systems in the treatment of ulcerative colitis and Crohn's disease release the active drug at the least effective location for treatment. The pharmaceutical industry has been developing different delivery systems for Multi-Matrix System (MMX) mesalamine for the treatment of ...
clinical response as an immediate UC treatment target, clinical remission as an intermediate treatment target, and endoscopic healing as a long-term target; moreover, the statement notes that clinical response and remission are more valuable as therapeutic goals in UC than in...
(Crohn disease, ulcerative colitis, psoriatic arthritis, systemic lupus erythematosus, systemic sclerosis, sicca syndrome, rheumatoid arthritis, Felty syndrome, juvenile chronic polyarthritis, juvenile idiopathic arthritis, ankylosing spondylitis, dermatomyositis, polymyositis, eosinophilia myalgia syndrome, other ...
JAK inhibitors;small molecules;IBD;ulcerative colitis;Crohn’s disease 1. Introduction Inflammatory bowel disease (IBD), such as Crohn’s disease (CD) and ulcerative colitis (UC) are chronic, progressive, and inflammatory disorders, characterized by alternating episodes of relapse and remission, invo...
For the analysis of the tissue cellular reaction to the bone sub- stitutes by a subcutaneous implantation model, eighty 6- to 8- week-old female Wistar rats from Charles River Laboratories (Ger- many) were randomly divided into five study groups (n = 4 per group and time point), (Table...
METHODS A literature search on Medline was conducted to identify relevant articles by using the key words "gastrointesti- nal disease" and "autism." Results of the search were complemented by ad- ditional publications identified by par- ticipants. Each article was assigned to 2 working group ...